Real-world Effectiveness of Anifrolumab in Adults with SLE: A 3-Month Interim Analysis of a Multinational Prospective Observational Cohort (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2220; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Observational data • Real-world • Real-world effectiveness • Real-world evidence • Inflammatory Arthritis
|
|
Samar Al Emadi, MD; FRCPC; FACR
|